Skip to main content
. Author manuscript; available in PMC: 2017 Aug 30.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2016 Mar 10;36(5):928–941. doi: 10.1161/ATVBAHA.115.306725

Table 3.

Top 20 KDs Based on an Overall Ranking Score Derived From 3 Data-Driven Criteria

KD Meta P Value for KDA P Value for GWAS Enrichment Meta P Value for Differential Expression Score 1 (KDA Strength and Consistency) Score 2 (Subnetwork Enrichment for CARDIoGRAM-C4D GWAS Signals) Score 3 (Gene Expression Alterations Between CAD and Controls) Summary Score
LUM 5.74e−08 1.14e−03 1.38e−13 0.935 0.923 0.978 2.836
COL1A1 4.13e−06 1.14e−03 1.55e−05 0.848 0.923 0.819 2.590
DUSP6 1.35e−34 6.82e−03 1.00e−16 1.000 0.538 1.000 2.538
HGD 1.05e−08 1.14e−03 3.76e−02 0.957 0.923 0.616 2.496
MSN 7.30e−06 4.55e−03 4.44e−16 0.826 0.619 0.993 2.438
CXCL12 2.28e−05 1.14e−03 1.62e−02 0.797 0.923 0.652 2.372
DUSP1 2.77e−26 1.02e−02 2.46e−08 0.993 0.427 0.928 2.348
GBP2 1.60e−07 3.41e−03 9.42e−04 0.920 0.698 0.725 2.343
MTMR11 8.93e−07 1.14e−03 3.61e−01 0.913 0.923 0.486 2.322
CCL18 1.39e−06 9.09e−03 8.61e−11 0.877 0.474 0.949 2.300
SLIT3 2.04e−04 1.00e−03 2.44e−01 0.717 1.000 0.507 2.225
GBP1 3.41e−08 1.82e−02 1.05e−11 0.942 0.226 0.964 2.132
F2 4.22e−13 1.14e−03 9.53e−01 0.971 0.923 0.232 2.126
COL4A2 4.04e−06 5.68e−03 1.94e−03 0.855 0.582 0.688 2.126
LOXL2 1.68e−04 3.41e−03 2.96e−02 0.725 0.698 0.638 2.061
CXCL10 2.74e−04 1.02e−02 3.37e−12 0.659 0.427 0.971 2.058
ANXA3 3.06e−03 1.14e−03 7.02e−07 0.246 0.923 0.877 2.046
SLC2A3 2.74e−04 7.95e−03 4.76e−07 0.652 0.500 0.884 2.036
SHC1 4.26e−03 1.14e−03 1.32e−09 0.167 0.923 0.942 2.032
STAT3 3.50e−03 1.00e−03 3.27e−05 0.210 1.000 0.812 2.022

CAD indicates coronary artery disease; CARDIoGRAM-C4D, Coronary Artery Disease Genome Wide Replication and Meta-Analysis Plus the Coronary Artery Disease Consortium; KDA, key driver analysis; and GWAS, genome-wide association studies.